Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing

Arctic Therapeutics Iceland United States of America

Funding will accelerate the company's anti-amyloid treatment for rare and common forms of dementia.As well as bringing forward a new class of treatment for inflammatory skin diseases.Sanos Group CEO Jeppe Ragnar Andersen joins the board.View original content:https://www.prnewswire.co.uk/news-releases/arctic-therapeutics-announces-26-5m-oversubscribed-series-a-financing-302357182.html